The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 clinical trial testing DPX-Survivac and metronomic low dose cyclophosphamide as immunotherapy for patients with recurrent diffuse large b-cell lymphoma.
 
Neil Lorne Berinstein
Consulting or Advisory Role - Immunovaccine
 
Richard H. C. Van Der Jagt
No Relationships to Disclose
 
Matthew C. Cheung
No Relationships to Disclose
 
Rena Buckstein
No Relationships to Disclose
 
Mohan Karkada
Employment - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - Immunovaccine
 
Tara Quinton
Employment - Immunovaccine
 
Lisa MacDonald
Employment - Immunovaccine
 
Marianne Stanford
Employment - Immunovaccine
Patents, Royalties, Other Intellectual Property - Immunovaccine
 
Rita Nigam
Employment - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
 
Marc Mansour
Employment - Immunovaccine
Leadership - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - Immunovaccine